Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis
Clinical trial NCT01722214 · COMPLETED
Trial details
- NCT number
- NCT01722214
- Sponsor
- Innovaderm Research Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2015-12-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.